Bottom line
HBGHX vs XLV: the short answer
HBGHX (Hartford Healthcare Hls Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 1.19% — a difference of $111 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +3.2% for HBGHX.
Updated Nov 19, 2026
HBGHX vs XLV side by side
| HBGHX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Hartford | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.19% | 0.08% |
| Annual cost per $10k | $119 | $8 |
| 10-yr cost on $10k (prospectus) | $1,443 | $103 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0.02% |
| 1-yr return | +15.8% | +14.5% |
| 5-yr return (annualized) | +3.2% | +8.1% |
| 10-yr return (annualized) | +7.6% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $112.4M | $40.6B |
| Number of holdings | 79 | 65 |
| Portfolio turnover | 5% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
19 of HBGHX's top 25 holdings also appear in XLV's top 25.
| Holding | HBGHX | XLV |
|---|---|---|
| Eli Lilly & Co | 12.47% | 16.51% |
| Johnson & Johnson | 6.63% | 10.64% |
| Merck & Co Inc | 6.60% | 5.52% |
| UnitedHealth Group Inc | 4.72% | 6.57% |
| AbbVie Inc | 3.43% | 7.74% |
| Intuitive Surgical Inc | 2.99% | 2.45% |
| Elevance Health Inc | 2.96% | 1.46% |
| CVS Health Corp | 2.93% | 2.30% |
| Vertex Pharmaceuticals Inc | 2.69% | 2.19% |
| Danaher Corp | 2.65% | 2.09% |
| Abbott Laboratories | 2.10% | 2.75% |
| Cencora Inc | 2.07% | 0.96% |
| Cardinal Health Inc | 1.81% | 0.97% |
| Thermo Fisher Scientific Inc | 1.64% | 3.24% |
| HCA Healthcare Inc | 1.60% | 1.05% |
Source: SEC Form N-PORT
HBGHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between HBGHX and XLV?
HBGHX (Hartford Healthcare Hls Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.19% — a difference of $111 a year per $10,000 invested.
Which is cheaper, HBGHX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both HBGHX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.